The Pfizer-BioNTech COVID-19 vaccine became the first vaccine to receive the World Health Organisation (WHO) validation for emergency use since the pandemic outbreak.
“Regulatory experts from around the world reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy and quality. They found that the vaccine met the must-have criteria for safety, efficacy and that the benefits of using it to address the disease offset potential risks,” WHO Tweeted.
The Pfizer/BioNTech #COVID19 vaccine today became the first vaccine to receive WHO validation for emergency use since the outbreak began.
— World Health Organization (WHO) (@WHO) December 31, 2020
Equitable global access to vaccines is crucial to combat the pandemic.
š https://t.co/7WNcHhc3z8 pic.twitter.com/Kyjv5RNzjB
Regulatory experts from around the š reviewed the data on the Pfizer/BioNTech #COVID19 vaccineās safety, efficacy & quality. They found that the vaccine met the must-have criteria for safety & efficacy & that the benefits of using it to address the disease offset potential risks pic.twitter.com/XSCQIDlw9b
— World Health Organization (WHO) (@WHO) December 31, 2020
Reopening of Gaza's Rafah crossing expected Monday
Winter storm death toll in United States reaches 90
Pakistan says 145 militants killed after attacks in Balochistan
Israeli strikes kill 26 in Gaza, health officials say
US government starts likely brief shutdown as House fails to approve deal
Thousands demonstrate in Minnesota and across US to protest ICE
France tightens infant milk rules after recalls
Modi ally proposes social media ban for India's teens as global debate grows
